MIRA Pharmaceuticals, Inc. (MIRA)
0.70
-0.05
(-6.10%)
USD |
NASDAQ |
Oct 12, 16:00
0.70
0.00 (0.00%)
After-Hours: 20:00
MIRA Pharmaceuticals Total Liabilities (Quarterly) : 0.0408M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0408M |
| March 31, 2026 | 0.1148M |
| December 31, 2025 | 0.7021M |
| September 30, 2025 | 0.0839M |
| June 30, 2025 | 0.2985M |
| March 31, 2025 | 0.1062M |
| December 31, 2024 | 0.7233M |
| September 30, 2024 | 0.6928M |
| June 30, 2024 | 0.7966M |
| Date | Value |
|---|---|
| March 31, 2024 | 0.652M |
| December 31, 2023 | 0.5581M |
| September 30, 2023 | 0.9029M |
| June 30, 2023 | 2.628M |
| March 31, 2023 | 2.187M |
| December 31, 2022 | 1.454M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 0.6705M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Resonate Blends, Inc. | 8.188M |
| Breakthrough Chemistry, Inc. | 0.4631M |
| Kaya Holdings, Inc. | 2.920M |
| Cardiac Biotech Solutions, Inc. | 2.726M |
| Endexx Corp. | 35.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.203M |
| Shareholders Equity (Quarterly) | 8.162M |
| Current Ratio | 200.19 |